awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q33410022-727B9D56-6EB8-417D-9FE3-F21028457A74
Q33410022-727B9D56-6EB8-417D-9FE3-F21028457A74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410022-727B9D56-6EB8-417D-9FE3-F21028457A74
Phase I clinical trial of lenalidomide in combination with temsirolimus in patients with advanced cancer.
P2860
Q33410022-727B9D56-6EB8-417D-9FE3-F21028457A74
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33410022-727B9D56-6EB8-417D-9FE3-F21028457A74
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3e516e07a2c7360d78bab5cc50f3712a742625b6
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.